Alterola Biotech Inc (OTCMKTS:ALTA) declared a quarterly dividend on Friday, July 31st, Wall Street Journal reports. Investors of record on Monday, August 10th will be given a dividend of 0.13 per share on Monday, August 17th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 2.77%. The ex-dividend date of this dividend is Friday, August 7th.
Alterola Biotech stock opened at $18.75 on Friday. Alterola Biotech has a 52-week low of $13.55 and a 52-week high of $31.27. The company’s fifty day simple moving average is $12.70.
Alterola Biotech (OTCMKTS:ALTA) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.55 EPS for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.08. The business had revenue of $31.91 million during the quarter, compared to the consensus estimate of $30.39 million.
In other Alterola Biotech news, Director Jr. Fred W. Fairclough sold 3,750 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $20.26, for a total transaction of $75,975.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Russell Gunther sold 1,600 shares of the company’s stock in a transaction on Monday, July 13th. The shares were sold at an average price of $20.75, for a total value of $33,200.00. Following the completion of the transaction, the insider now directly owns 70,724 shares in the company, valued at $1,467,523. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,605 shares of company stock worth $371,780.
Alterola Biotech Company Profile
Alterola Biotech, Inc, a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums.
Further Reading: Do Tariffs Work?
Receive News & Ratings for Alterola Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterola Biotech and related companies with MarketBeat.com's FREE daily email newsletter.